$IVZ
Invesco Ltd. Stock $ivz

$ivz Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000091420821000459 Filed on July 30, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$1.721B	$1.419B
YoY Change	21.31%	-1.42%
Cost Of Revenue	$539.6M	$444.0M
YoY Change	21.53%	-1.73%
Gross Profit	$1.182B	$975.0M
YoY Change	21.21%	-1.28%
Gross Profit Margin	68.65%	68.71%
Selling, General & Admin	$127.8M	$203.3M
YoY Change	-37.14%	59.33%
% of Gross Profit	10.81%	20.85%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$52.80M	$50.30M
YoY Change	4.97%	24.81%
% of Gross Profit	4.47%	5.16%
Operating Expenses	$1.251B	$1.302B
YoY Change	-3.95%	-8.39%
Operating Profit	$470.9M	$117.1M
YoY Change	302.13%	539.89%
Interest Expense	$24.60M	$34.80M
YoY Change	-29.31%	5.45%
% of Operating Profit	5.22%	29.72%
Other Income/Expense, Net	$43.40M	$60.00M
YoY Change	-27.67%	148.96%
Pretax Income	$649.3M	$105.4M
YoY Change	516.03%	37.78%
Income Tax	$154.2M	$43.40M
% Of Pretax Income	23.75%	41.18%
Net Earnings	$368.3M	$40.50M
YoY Change	809.38%	1.0%
Net Earnings / Revenue	21.4%	2.85%
Basic Earnings Per Share	$0.80	$0.09
Diluted Earnings Per Share	$0.79	$0.09
COMMON SHARES
Basic Shares Outstanding	462.8M shares	460.1M shares
Diluted Shares Outstanding	466.2M shares	463.1M shares

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.333B	$987.0M
YoY Change	35.06%	-17.68%
Cash & Equivalents	$1.333B	$987.1M
Short-Term Investments
Other Short-Term Assets	$139.6M	$129.0M
YoY Change	8.22%	-7.19%
Inventory
Prepaid Expenses
Receivables	$1.024B	$830.0M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.496B	$1.946B
YoY Change	28.27%	-15.83%
LONG-TERM ASSETS
Property, Plant & Equipment	$524.8M	$555.1M
YoY Change	-5.46%	-2.24%
Goodwill	$8.962B	$8.618B
YoY Change	3.98%	2.73%
Intangibles	$7.267B	$7.313B
YoY Change	-0.63%	-0.87%
Long-Term Investments	$481.9M	$355.1M
YoY Change	35.71%	14.36%
Other Assets
YoY Change
Total Long-Term Assets	$30.75B	$33.63B
YoY Change	-8.57%	-7.06%
TOTAL ASSETS
Total Short-Term Assets	$2.496B	$1.946B
Total Long-Term Assets	$30.75B	$33.63B
Total Assets	$33.25B	$35.58B
YoY Change	-6.55%	-7.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.485B	$1.522B
YoY Change	-2.43%	-3.12%
Accrued Expenses	$742.4M	$932.0M
YoY Change	-20.34%	-15.73%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.930B	$10.59B
YoY Change	-44.02%	-26.6%
LONG-TERM LIABILITIES
Long-Term Debt	$8.835B	$8.655B
YoY Change	2.07%	19.05%
Other Long-Term Liabilities	$1.119B	$653.0M
YoY Change	71.3%	15.37%
Total Long-Term Liabilities	$9.953B	$9.308B
YoY Change	6.93%	18.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.930B	$10.59B
Total Long-Term Liabilities	$9.953B	$9.308B
Total Liabilities	$17.46B	$21.41B
YoY Change	-18.45%	-10.07%
SHAREHOLDERS EQUITY
Retained Earnings	$6.570B	$5.825B
YoY Change	12.79%	-0.54%
Common Stock	$7.778B	$7.902B
YoY Change	-1.57%	-0.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$3.080B	$3.319B
YoY Change	-7.19%	4.2%
Treasury Stock Shares
Shareholders Equity	$14.91B	$13.60B
YoY Change
Total Liabilities & Shareholders Equity	$33.25B	$35.58B
YoY Change	-6.55%	-7.59%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	$368.3M	$40.50M
YoY Change	809.38%	1.0%
Depreciation, Depletion And Amortization	$52.80M	$50.30M
YoY Change	4.97%	24.81%
Cash From Operating Activities	$507.7M	$347.4M
YoY Change	46.14%	-24.49%
INVESTING ACTIVITIES
Capital Expenditures	-$26.90M	-$28.00M
YoY Change	-3.93%	0.36%
Acquisitions
YoY Change
Other Investing Activities	-$56.90M	-$263.0M
YoY Change	-78.37%	52.02%
Cash From Investing Activities	-$83.80M	-$291.0M
YoY Change	-71.2%	44.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-482.7M	-25.00M
YoY Change	1830.8%	-71.91%
NET CHANGE
Cash From Operating Activities	507.7M	347.4M
Cash From Investing Activities	-83.80M	-291.0M
Cash From Financing Activities	-482.7M	-25.00M
Net Change In Cash	-58.80M	31.40M
YoY Change	-287.26%	-81.55%
FREE CASH FLOW
Cash From Operating Activities	$507.7M	$347.4M
Capital Expenditures	-$26.90M	-$28.00M
Free Cash Flow	$534.6M	$375.4M
YoY Change	42.41%	-23.07%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000914208
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-13908
	dei	Entity Registrant Name EntityRegistrantName	Invesco Ltd.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	D0
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0557567
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1555 Peachtree Street, N.E.,
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1800,
	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30309
	dei	City Area Code CityAreaCode	404
	dei	Local Phone Number LocalPhoneNumber	892-0896
	dei	Security12b Title Security12bTitle	Common stock, $.20 par value
	dei	Trading Symbol TradingSymbol	IVZ
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	461391784	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1333000000.0	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1408400000	USD
CY2021Q2	ivz	Unsettled Fund Receivables UnsettledFundReceivables	287600000	USD
CY2020Q4	ivz	Unsettled Fund Receivables UnsettledFundReceivables	109400000	USD
CY2021Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	736000000.0	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	741100000	USD
CY2021Q2	us-gaap	Investments Investments	965200000	USD
CY2020Q4	us-gaap	Investments Investments	826800000	USD
CY2021Q2	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	404100000	USD
CY2020Q4	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	301700000	USD
CY2021Q2	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	488300000	USD
CY2020Q4	ivz	Accountsreceivableandotherassetsofconsolidatedinvestmentproducts Accountsreceivableandotherassetsofconsolidatedinvestmentproducts	175500000	USD
CY2021Q2	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	8304800000	USD
CY2020Q4	ivz	Investments Of Consolidated Investment Products InvestmentsOfConsolidatedInvestmentProducts	7910000000.0	USD
CY2021Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	3415200000	USD
CY2020Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	7582100000	USD
CY2021Q2	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	139600000	USD
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	149200000	USD
CY2021Q2	us-gaap	Other Assets OtherAssets	420800000	USD
CY2020Q4	us-gaap	Other Assets OtherAssets	514200000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	524800000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	563800000	USD
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7267300000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7305600000	USD
CY2021Q2	us-gaap	Goodwill Goodwill	8961700000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	8916300000	USD
CY2021Q2	us-gaap	Assets Assets	33248400000	USD
CY2020Q4	us-gaap	Assets Assets	36504100000	USD
CY2021Q2	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	742400000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	973700000	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1485000000.0	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	1920400000	USD
CY2021Q2	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6750700000	USD
CY2020Q4	ivz	Long Term Debt Of Consolidated Investment Products LongTermDebtOfConsolidatedInvestmentProducts	6714100000	USD
CY2021Q2	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	1118600000	USD
CY2020Q4	ivz	Otherliabilitiesofconsolidatedinvestmentproducts Otherliabilitiesofconsolidatedinvestmentproducts	588600000	USD
CY2021Q2	us-gaap	Separate Accounts Liability SeparateAccountsLiability	3415200000	USD
CY2020Q4	us-gaap	Separate Accounts Liability SeparateAccountsLiability	7582100000	USD
CY2021Q2	ivz	Unsettled Fund Payables UnsettledFundPayables	286900000	USD
CY2020Q4	ivz	Unsettled Fund Payables UnsettledFundPayables	98400000	USD
CY2021Q2	us-gaap	Long Term Debt LongTermDebt	2083800000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	2082600000	USD
CY2021Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1575300000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1523500000	USD
CY2021Q2	us-gaap	Liabilities Liabilities	17457900000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	21483400000	USD
CY2021Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	363900000	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	211800000	USD
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.20
CY2021Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2020Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000.0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	4000000.0	shares
CY2021Q2	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	4010500000	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.20
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000.0	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1050000000.0	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	113200000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	113200000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7664300000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7811400000	USD
CY2021Q2	us-gaap	Treasury Stock Value TreasuryStockValue	3080300000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	3253800000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6570100000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6085000000.0	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-369800000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-404500000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	14908000000.0	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	14361800000	USD
CY2021Q2	us-gaap	Minority Interest MinorityInterest	518600000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	447100000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15426600000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33248400000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	36504100000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1721400000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1419000000.0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3381100000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3017900000	USD
CY2021Q2	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	539600000	USD
CY2020Q2	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	444000000.0	USD
	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	1062400000	USD
	ivz	Third Party Distribution Service And Advisory ThirdPartyDistributionServiceAndAdvisory	959100000	USD
CY2021Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	487000000.0	USD
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	454600000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	976200000	USD
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	876500000	USD
CY2021Q2	us-gaap	Marketing Expense MarketingExpense	24500000	USD
CY2020Q2	us-gaap	Marketing Expense MarketingExpense	14400000	USD
	us-gaap	Marketing Expense MarketingExpense	40300000	USD
	us-gaap	Marketing Expense MarketingExpense	47100000	USD
CY2021Q2	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	127200000	USD
CY2020Q2	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	128300000	USD
	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	256500000	USD
	us-gaap	Communications Information Technology And Occupancy CommunicationsInformationTechnologyAndOccupancy	258700000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	103300000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	188900000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	199900000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	295200000	USD
CY2021Q2	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	-47100000	USD
CY2020Q2	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	56500000	USD
	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	-1300000	USD
	ivz	Total Transaction And Integration Charges TotalTransactionAndIntegrationCharges	116100000	USD
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	16000000.0	USD
CY2020Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31900000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	31100000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	1250500000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	1301900000	USD
	us-gaap	Operating Expenses OperatingExpenses	2565900000	USD
	us-gaap	Operating Expenses OperatingExpenses	2583800000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	470900000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	117100000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	815200000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	434100000	USD
CY2021Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	37200000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	11200000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	64700000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28100000	USD
CY2021Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	400000	USD
CY2020Q2	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	2400000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	1700000	USD
	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	8800000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	24600000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	34800000	USD
	us-gaap	Interest Expense InterestExpense	48400000	USD
	us-gaap	Interest Expense InterestExpense	71100000	USD
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	43400000	USD
CY2020Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	60000000.0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	77500000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46500000	USD
CY2021Q2	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	122000000.0	USD
CY2020Q2	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	-50500000	USD
	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	216700000	USD
	ivz	Other Nonoperating Income Expense Consolidated Investment Products OtherNonoperatingIncomeExpenseConsolidatedInvestmentProducts	-70600000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	649300000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	105400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1127400000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	282800000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	154200000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43400000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	260700000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	100800000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	495100000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	62000000.0	USD
	us-gaap	Profit Loss ProfitLoss	866700000	USD
	us-gaap	Profit Loss ProfitLoss	182000000.0	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	67600000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-37700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	112200000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-58400000	USD
CY2021Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	USD
CY2020Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	118400000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	118400000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	368300000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	40500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	636100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	122000000.0	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2021Q2	us-gaap	Profit Loss ProfitLoss	495100000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	62000000.0	USD
	us-gaap	Profit Loss ProfitLoss	866700000	USD
	us-gaap	Profit Loss ProfitLoss	182000000.0	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34900000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86200000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	35700000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-228800000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	3000000.0	USD
CY2020Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	3300000	USD
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-1000000.0	USD
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-228700000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	533000000.0	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	37900000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89500000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	151500000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	901400000	USD
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-46700000	USD
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	67600000	USD
CY2020Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-37700000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	112200000	USD
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-58400000	USD
CY2021Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	USD
CY2020Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	59200000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	118400000	USD
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	118400000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	406200000	USD
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	130000000.0	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	670800000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-106700000	USD
	us-gaap	Profit Loss ProfitLoss	866700000	USD
	us-gaap	Profit Loss ProfitLoss	182000000.0	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103900000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98700000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	72800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	95200000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	77500000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-46500000	USD
	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	160800000	USD
	ivz	Gains And Losses Of Consolidated Investment Products Net GainsAndLossesOfConsolidatedInvestmentProductsNet	-126100000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	64700000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	28100000	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	43000000.0	USD
	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	29300000	USD
	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	135400000	USD
	ivz	Purchasesaleofinvestmentsby Ci Pnet PurchasesaleofinvestmentsbyCIPnet	24400000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	20500000	USD
	us-gaap	Payments For Proceeds From Short Term Investments PaymentsForProceedsFromShortTermInvestments	-174500000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-4090100000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-2391500000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-4236800000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2830400000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	480800000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	260900000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47200000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47000000.0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	-200000	USD
	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	3224500000	USD
	ivz	Purchase Of Investments By Consolidated Investment Products PurchaseOfInvestmentsByConsolidatedInvestmentProducts	2742700000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	34900000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	118400000	USD
	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	3076100000	USD
	ivz	Proceeds From Sale Of Investments By Consolidated Investment Products ProceedsFromSaleOfInvestmentsByConsolidatedInvestmentProducts	2041400000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	100600000	USD
	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	73000000.0	USD
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	76800000	USD
	us-gaap	Proceeds From Sale Of Other Investments ProceedsFromSaleOfOtherInvestments	93500000	USD
	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	4400000	USD
	ivz	Proceeds From Returns Of Capital And Distributions From Equity Method Investments ProceedsFromReturnsOfCapitalAndDistributionsFromEquityMethodInvestments	13700000	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	0	USD
	us-gaap	Payments For Proceeds From Derivative Instrument Investing Activities PaymentsForProceedsFromDerivativeInstrumentInvestingActivities	28700000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215000000.0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-743000000.0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	47600000	USD
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	118400000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	150100000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	214500000	USD
	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	247300000	USD
	ivz	Capital Invested Into Consolidated Investment Products CapitalInvestedIntoConsolidatedInvestmentProducts	82500000	USD
	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	117100000	USD
	ivz	Capital Distributed By Consolidated Investment Products CapitalDistributedByConsolidatedInvestmentProducts	153400000	USD
	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	2138600000	USD
	ivz	Proceedsfrom Debt Consolidated Investment Products ProceedsfromDebtConsolidatedInvestmentProducts	1075100000	USD
	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	1872300000	USD
	ivz	Repayments Of Consolidated Investment Products RepaymentsOfConsolidatedInvestmentProducts	686100000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	309400000	USD
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	190600000	USD
	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	-104100000	USD
	ivz	Proceeds From Payments For Collateral Financing Activities ProceedsFromPaymentsForCollateralFinancingActivities	0	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	325600000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	11800000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	14000000.0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-344900000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	71300000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-79100000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-410800000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-9700000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-28300000	USD
	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	-4700000	USD
	ivz	Effectof Exchange Rateon Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Cip EffectofExchangeRateonCashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsCIP	-100000	USD
	ivz	Deconsolidationof Consolidated Investment Products Net DeconsolidationofConsolidatedInvestmentProductsNet	8700000	USD
	ivz	Deconsolidationof Consolidated Investment Products Net DeconsolidationofConsolidatedInvestmentProductsNet	-9200000	USD
CY2020Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1839300000	USD
CY2019Q4	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1701200000	USD
CY2021Q2	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1737100000	USD
CY2020Q2	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1271200000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1333000000.0	USD
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	987100000	USD
CY2021Q2	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	404100000	USD
CY2020Q2	ivz	Cash And Cash Equivalents Of Consolidated Investment Products CashAndCashEquivalentsOfConsolidatedInvestmentProducts	284100000	USD
CY2021Q2	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1737100000	USD
CY2020Q2	ivz	Cash Cash Equivalents Restricted Cashand Restricted Cash Equivalents Including Cip CashCashEquivalentsRestrictedCashandRestrictedCashEquivalentsIncludingCIP	1271200000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	129200000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15029500000	USD
CY2021Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	479300000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	37900000	USD
CY2021Q2	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	14900000	USD
CY2021Q2	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	14.75
CY2021Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	59200000	USD
CY2021Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.170
CY2021Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	78100000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	34200000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	800000	USD
CY2021Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2900000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15426600000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13942400000	USD
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	39300000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89500000	USD
CY2020Q2	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	17000000.0	USD
CY2020Q2	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	14.75
CY2020Q2	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	59200000	USD
CY2020Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.155
CY2020Q2	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	72100000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47800000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	400000	USD
CY2020Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	3400000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13967700000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14808900000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	849100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34700000	USD
	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	23100000	USD
	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	29.50
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	118400000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.325
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	151000000.0	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	72800000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	1200000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	47600000	USD
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	15426600000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14318300000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	204400000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-228700000	USD
	ivz	Change In Noncontrolling Interests In Consolidated Entities Net ChangeInNoncontrollingInterestsInConsolidatedEntitiesNet	54100000	USD
	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	29.50
	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	118400000	USD
	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.465
	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	214800000	USD
CY2021Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	3400000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	95200000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	700000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	34900000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	13967700000	USD
CY2021Q2	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	3415200000	USD
CY2021Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	4692000000.0	USD
CY2020Q4	us-gaap	Other Assets Fair Value Disclosure OtherAssetsFairValueDisclosure	7582100000	USD
CY2020Q4	us-gaap	Derivative Assets DerivativeAssets	5100000	USD
CY2020Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	8894800000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	18600000	USD
CY2021Q2	ivz	Foreign Time Deposits ForeignTimeDeposits	28300000	USD
CY2020Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	29900000	USD
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	481900000	USD
CY2021Q2	us-gaap	Other Investments OtherInvestments	10100000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	426100000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	10500000	USD
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	481900000	USD
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	426100000	USD
CY2021Q2	ivz	Foreign Time Deposits ForeignTimeDeposits	28300000	USD
CY2020Q4	ivz	Foreign Time Deposits ForeignTimeDeposits	29900000	USD
CY2021Q2	us-gaap	Other Investments OtherInvestments	10100000	USD
CY2020Q4	us-gaap	Other Investments OtherInvestments	10500000	USD
CY2021Q2	us-gaap	Investments Investments	965200000	USD
CY2020Q4	us-gaap	Investments Investments	826800000	USD
CY2021Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	4000000.0	shares
CY2021Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	4000000.0	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
	ivz	Preferred Stock Lockup Period PreferredStockLockupPeriod	P5Y
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	566100000	shares
CY2021Q2	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	104700000	shares
CY2020Q4	ivz	Treasury Stock Shares For Which Dividendand Voting Rights Do Not Apply TreasuryStockSharesForWhichDividendandVotingRightsDoNotApply	107000000.0	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	461400000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	459100000	shares
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	34900000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	3000000.0	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	37900000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	37900000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	35700000	USD
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	-1000000.0	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	34700000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86200000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	3300000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89500000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	89500000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-228800000	USD
	us-gaap	Other Comprehensive Income Other Net Of Tax OtherComprehensiveIncomeOtherNetOfTax	100000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-228700000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-228700000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-2200000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-7900000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1900000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	9400000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1721400000	USD
CY2020Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1419000000.0	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3381100000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3017900000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	58000000.0	USD
CY2021Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	59800000	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	45800000	USD
CY2020Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	58000000.0	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	72800000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	95200000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	18.74
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	21.85
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	18.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	152300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	94300000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	22.60
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	14.09
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	231100000	USD
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y5M12D
CY2021Q2	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	20100000	USD
	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	50100000	USD
	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	0	USD
CY2020Q2	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	0	USD
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	94100000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	49600000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	44500000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	23900000	USD
CY2021Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	41300000	USD
CY2021Q1	us-gaap	Restructuring Reserve RestructuringReserve	27100000	USD
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	15900000	USD
CY2021Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	24700000	USD
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	18300000	USD
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	24900000	USD
	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	10300000	USD
CY2021	us-gaap	Restructuring Reserve Settled Without Cash2 RestructuringReserveSettledWithoutCash2	35200000	USD
CY2021Q2	us-gaap	Restructuring And Related Cost Cost Incurred To Date1 RestructuringAndRelatedCostCostIncurredToDate1	169100000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	368300000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	40500000	USD
	us-gaap	Net Income Loss NetIncomeLoss	636100000	USD
	us-gaap	Net Income Loss NetIncomeLoss	122000000.0	USD
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	462800000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	460100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	462200000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	457900000	shares
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3400000	shares
CY2020Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000.0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3100000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3100000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	466200000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	463100000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	465300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	461000000.0	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.80
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.38
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.79
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	427700000	USD
CY2020	ivz	Undrawn Capital Commitments UndrawnCapitalCommitments	453500000	USD
	us-gaap	Variable Interest Entity Number Of Entities With Unavailability Of Information VariableInterestEntityNumberOfEntitiesWithUnavailabilityOfInformation	5	entity
	ivz	Voting Rights Entity Nonconsolidated Numberof Entities VotingRightsEntityNonconsolidatedNumberofEntities	4	entity
	us-gaap	Variable Interest Entity Number Of Entities With Unavailability Of Information VariableInterestEntityNumberOfEntitiesWithUnavailabilityOfInformation	6	entity
	ivz	Voting Rights Entity Nonconsolidated Numberof Entities VotingRightsEntityNonconsolidatedNumberofEntities	11	entity
	ivz	Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High CollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.120
CY2021Q2	ivz	Collateral Assets Default Percentage CollateralAssetsDefaultPercentage	0.0061
	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread Low NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadLow	0.0040
	ivz	Issued Note Maturity Average Years IssuedNoteMaturityAverageYears	P10Y9M29D
	ivz	Notes Issued By Collateralized Loan Obligations Terms Of Arrangements Interest Rate Margin Spread High NotesIssuedByCollateralizedLoanObligationsTermsOfArrangementsInterestRateMarginSpreadHigh	0.0851
CY2021Q2	us-gaap	Due From Affiliates DueFromAffiliates	822600000	USD
CY2020Q4	us-gaap	Due From Affiliates DueFromAffiliates	612000000.0	USD
CY2021Q2	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	368900000	USD
CY2020Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	171600000	USD

Files In Submission

Name	View Source	Status
0000914208-21-000459-index-headers.html	Edgar Link	pending
0000914208-21-000459-index.html	Edgar Link	pending
0000914208-21-000459.txt	Edgar Link	pending
0000914208-21-000459-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_01.jpg	Edgar Link	pending
image_02.jpg	Edgar Link	pending
image_03.jpg	Edgar Link	pending
image_1.jpg	Edgar Link	pending
image_11.jpg	Edgar Link	pending
image_12.jpg	Edgar Link	pending
ivz-20210630.htm	Edgar Link	pending
ivz-20210630.xsd	Edgar Link	pending
ivz-20210630_cal.xml	Edgar Link	unprocessable
ivz-20210630_def.xml	Edgar Link	unprocessable
ivz-20210630_g1.jpg	Edgar Link	pending
ivz-20210630_htm.xml	Edgar Link	completed
ivz-20210630_lab.xml	Edgar Link	unprocessable
ivz-20210630_pre.xml	Edgar Link	unprocessable
ivz2q2021ex101.htm	Edgar Link	pending
ivz2q2021ex102.htm	Edgar Link	pending
ivz2q2021ex103.htm	Edgar Link	pending
ivz2q2021ex104.htm	Edgar Link	pending
ivz2q2021ex311.htm	Edgar Link	pending
ivz2q2021ex312.htm	Edgar Link	pending
ivz2q2021ex321.htm	Edgar Link	pending
ivz2q2021ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVZ
Invesco Ltd. Stock $ivz

2021 Q2 Form 10-Q Financial Statement

#000091420821000459 Filed on July 30, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ Invesco Ltd. Stock $ivz

2021 Q2 Form 10-Q Financial Statement

#000091420821000459 Filed on July 30, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVZ
Invesco Ltd. Stock $ivz